about
Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaireNine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical TreatmentAdaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer.Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiation.Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer.Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.Holistic needs assessment and care plans for women with gynaecological cancer: do they improve cancer-specific health-related quality of life? A randomised controlled trial using mixed methods.Intensity-modulated Radiotherapy and Anal Cancer: Clinical Outcome and Late Toxicity Assessment.MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy.Medium-term outcomes of active surveillance for localised prostate cancer.A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocMagnitude of observer error using cone beam CT for prostate interfraction motion estimation: effect of reducing scan length or increasing exposure.Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillance.Outcomes from treating bile acid malabsorption using a multidisciplinary approach.Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance.Predicting late effects of pelvic radiotherapy: is there a better approach?Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation.Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial.Clinical trial: Efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignancies.Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response.Magnetic Resonance Imaging Prediction of an Involved Surgical Resection Margin in Low Rectal CancerSites of surgical waisting in the abdominoperineal specimen“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2MutationsIn Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation TherapyEfficacy of Palliative Low-Dose Involved-Field Radiation Therapy in Advanced Lymphoma: A Phase II StudyProstate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling timeDosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer.Efficacy of low-dose dexamethasone in castration-refractory prostate cancerCan diet combined with treatment scheduling achieve consistency of rectal filling in patients receiving radiotherapy to the prostate?Diethylstilbestrol in castration-resistant prostate cancerLetter in response to article: a pilot study examining circulating interleukin-6 and transforming growth factor-β levels during pelvic radiation therapyA randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancerCervical Spine Fractures in Patients Undergoing Palliative Radiotherapy to the Cervical Spine: Implications for PracticeFilling the gaps: A mixed-methods study exploring the use of patient diaries in the critical care unit
P50
Q28271652-6CDEB343-8B30-4A50-B78F-4BCD7F876218Q31008148-3CEA6ACA-D76D-4301-8E64-90F5CA8632D4Q33567416-C15A42C4-2DF3-428C-B400-3472A04465ADQ33578839-A7BDB5CC-CE65-462B-B895-A1B314CB88A6Q34596508-E93E3735-E485-4777-AD2E-4A3AB4C212E1Q34860838-A7043B10-31CD-4DC9-94EF-D4D9204DE64FQ34990107-F47FB47D-939D-451E-94D1-C09469E29827Q35973412-F3EBB7F1-0A67-40D0-A6BD-E3382D39D655Q37412876-CB2885EE-629D-435B-A54F-619F3A9AB6FAQ38605186-96D2D23A-B5E5-4A58-AFA6-229FB43AD42AQ38870125-DEC7CE5A-F6BA-42BF-868C-D25B0293A36BQ39869907-33AE8407-181F-49FC-A3CD-DC5D769DD151Q40096721-F5C68AF8-34B9-4673-8AFE-AF5E89814290Q41556432-A7F5EFFA-068A-4961-BB95-B9E2EB239D3EQ43063798-BF65D851-7113-4BDE-AB43-F8EF209DDC9CQ43112454-F9D93B3B-5250-42E4-A427-EB0B798BF0E4Q43329585-CFEB4FAF-ACE1-483B-8EED-1801F39311FAQ43502197-7BBBA87B-1002-41E9-958F-EC7775F05C2CQ43632067-0771FF8E-177D-4E23-BA2D-52703F146E58Q44052404-84A2FC9B-4215-4290-952C-C8D26F355D63Q45054216-D280DCFC-E21B-4885-B794-CA76506CE071Q45198533-6AD016B5-FA65-4E09-B892-7836C64A7D52Q46722010-5B2FD231-FA20-4008-AE7E-532A6549BAE8Q47367779-93B0D73F-D389-47E7-9279-EEEB2DB8A51EQ51345489-9D4860BA-E4A0-4723-BEF7-05A841890592Q54942771-ECAD4F19-D4E3-47CE-BD2F-CFB2122CA39DQ57088853-1F6625A4-23DD-4BBB-8086-CF53B7B1FEDBQ57088870-FD808BFF-B61F-4FBA-81CD-05C511D0D669Q57694467-76EA43EE-DA49-4A2D-8D73-D6E587380BF0Q59134271-D452255E-01A8-4E05-87DB-E16F61CC6758Q61868098-8AD77594-78CD-4D50-A48C-86F92F0C1D4CQ63966740-9C73E9B2-7643-4F5C-ADF1-A2ADDED511AFQ64971207-F08662F5-F10D-44DE-B35D-519536D06749Q81452484-236ABD30-38B9-4419-B402-C4F491065A60Q84918125-72F84E4D-A691-477B-A7A0-6ADF06F81770Q85315390-CF07B78F-6142-450B-BC54-F41BD7C5F7BBQ85925527-C6E38149-5528-4B91-88E7-08D2F04D5462Q86132975-618250D6-E454-43A4-B5BC-68EE0B932A64Q88353966-BD2D0871-710B-4619-93C9-744A96C1459FQ90679034-58794EB3-5C23-4982-8129-BFD426050D2C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7548-4466
@en
name
K Thomas
@ast
K Thomas
@en
K Thomas
@es
K Thomas
@nl
type
label
K Thomas
@ast
K Thomas
@en
K Thomas
@es
K Thomas
@nl
prefLabel
K Thomas
@ast
K Thomas
@en
K Thomas
@es
K Thomas
@nl
P106
P31
P496
0000-0001-7548-4466